Tag: NASDAQ:DYAX

Finance

Healthcare Bearish Stocks: Illumina (NASDAQ:ILMN), The Clorox Co (NYSE:CLX), Dyax Corp. (NASDAQ:DYAX), Alexion Pharmaceuticals (NASDAQ:ALXN)

Illumina (NASDAQ:ILMN) SVP Nicholas Naclerio unloaded 2,000 shares of Illumina stock in a transaction that occurred on Monday, March 17th. Illumina, Inc. (NASDAQ:ILMN) stock performance was -5.42% in last session and finished the day at $152.60. Traded volume was 4,483,791 million shares in the last session and the average volume of the stock remained 1.99 million shares. The beta of the stock remained 0.44. Illumina, … Continue reading Healthcare Bearish Stocks: Illumina (NASDAQ:ILMN), The Clorox Co (NYSE:CLX), Dyax Corp. (NASDAQ:DYAX), Alexion Pharmaceuticals (NASDAQ:ALXN)

Colin Pettis
BioTech

Biotech Top Losers: TESARO Inc. (NASDAQ:TSRO), Dyax Corp. (NASDAQ:DYAX), Regulus Therapeutics (NASDAQ:RGLS), Cara Therapeutics (NASDAQ:CARA)

Tesaro Inc. (NASDAQ:TSRO) announced Thursday morning that it has entered into an exclusive, worldwide license agreement and immuno-oncology antibody collaboration with AnaptysBio Inc. TESARO Inc. (NASDAQ:TSRO) stock performance was -5.40% in last session and finished the day at $36.76. Traded volume was 732,104.00 shares in the last session and the average volume of the stock remained 469,070.00 shares. TESARO Inc. (NASDAQ:TSRO) insider ownership is 21.88%. … Continue reading Biotech Top Losers: TESARO Inc. (NASDAQ:TSRO), Dyax Corp. (NASDAQ:DYAX), Regulus Therapeutics (NASDAQ:RGLS), Cara Therapeutics (NASDAQ:CARA)

John Bellich
BioTech

Biotech Gainers In News: Inovio Pharmaceuticals (NYSEMKT:INO), Dendreon Corporation (NASDAQ:DNDN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax (NASDAQ:DYAX)

Inovio Pharmaceuticals Inc (NYSEMKT:INO) on Feb. 27 announced the pricing of an underwritten public offering of 18,966,000 shares of common stock for a public offering price of $2.90 per share. The gross proceeds to Inovio from this offering are expected to be approximately $55 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. Inovio Pharmaceuticals Inc (NYSEMKT:INO) … Continue reading Biotech Gainers In News: Inovio Pharmaceuticals (NYSEMKT:INO), Dendreon Corporation (NASDAQ:DNDN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax (NASDAQ:DYAX)

Colin Pettis
Finance

Momentum Stocks : Southwest Airlines (NYSE:LUV), Dyax Corp. (NASDAQ:DYAX), Fossil Group (NASDAQ:FOSL), YY Inc. (NASDAQ:YY), Sony Corp (ADR) (NYSE:SNE)

Southwest Airlines Co. (NYSE:LUV) Chief Executive Officer Gary Kelly said, “I don’t see the need to do anything differently.” While Southwest doesn’t fly beyond the Caribbean and Mexico, it could pick up international passengers who fly into several U.S. gateways for flights across the country. Southwest Airlines Co. (NYSE:LUV) belongs to Services sector. Its net profit margin is 6.00% and weekly performance is -4.56%. On … Continue reading Momentum Stocks : Southwest Airlines (NYSE:LUV), Dyax Corp. (NASDAQ:DYAX), Fossil Group (NASDAQ:FOSL), YY Inc. (NASDAQ:YY), Sony Corp (ADR) (NYSE:SNE)

John Meady